Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Allan H Young, Mohamed Abdelghani, Mario F Juruena, Viktoriya L Nikolova & Ramin Nilforooshan. (2023) Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations. Neuropsychiatric Disease and Treatment 19, pages 433-441.
Read now
Read now
Tom Denee, Timothy Ming, John Waller, Tom Bailey, Olivera Rajkovic-Hooley, Chloe Middleton-Dalby, Hoa H. Le, Qiaoyi Zhang, Paul McCrone & David Taylor. (2021) A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom. Current Medical Research and Opinion 37:2, pages 311-319.
Read now
Read now
Susan McPherson, Felicitas Rost, Joel Town & Allan Abbass. (2018) Epistemological flaws in NICE review methodology and its impact on recommendations for psychodynamic psychotherapies for complex and persistent depression. Psychoanalytic Psychotherapy 32:2, pages 102-121.
Read now
Read now
Articles from other publishers (15)
Ssu-Ju Li, Yu-Chun Lo, Hsin-Yi Tseng, Sheng-Huang Lin, Chao-Hung Kuo, Ting-Chieh Chen, Ching-Wen Chang, Yao-Wen Liang, Yi-Chen Lin, Chih-Yu Wang, Tsai-Yu Cho, Mu-Hua Wang, Ching-Te Chen & You-Yin Chen. (2023) Nucleus accumbens deep brain stimulation improves depressive-like behaviors through BDNF-mediated alterations in brain functional connectivity of dopaminergic pathway. Neurobiology of Stress 26, pages 100566.
Crossref
Crossref
Jirada Prasartpornsirichoke, Nuttorn Pityaratstian, Chayanit Poolvoralaks, Naphat Sirinimnualkul, Tanaporn Ormtavesub, Nimmavadee Hiranwattana, Sasitorn Phonsit & Teerayuth Rungnirundorn. (2023) The prevalence and economic burden of treatment-resistant depression in Thailand. BMC Public Health 23:1.
Crossref
Crossref
Anya Borissova & James J. Rucker. (2023) The development of psilocybin therapy for treatment-resistant depression: an update. BJPsych Bulletin, pages 1-7.
Crossref
Crossref
Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne K. Schlag, David J. Nutt & Joanna C. Neill. (2023) Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model. Psychological Medicine, pages 1-8.
Crossref
Crossref
Shanaya Rathod, Tom Denee, Joe Eva, Cicely Kerr, Nicholas Jacobsen, Mitesh Desai, Laura Baldock & Allan H. Young. (2022) Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study. Journal of Affective Disorders 300, pages 551-562.
Crossref
Crossref
Rebecca Strawbridge, Paul McCrone, Andrea Ulrichsen, Roland Zahn, Jonas Eberhard, Danuta Wasserman, Paolo Brambilla, Giandomenico Schiena, Ulrich Hegerl, Judit Balazs, Jose Caldas de Almeida, Ana Antunes, Spyridon Baltzis, Vladmir Carli, Vinciane Quoidbach, Patrice Boyer & Allan H. Young. (2022) Care pathways for people with major depressive disorder: A European Brain Council Value of Treatment study. European Psychiatry 65:1.
Crossref
Crossref
Kinza Degerlund Maldi, Peter Asellus, Anna Myléus & Fredrik Norström. (2021) Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression. BMC Psychiatry 21:1.
Crossref
Crossref
Ericka C. Solis, Ingrid V. E. Carlier, Nic J. A. van der Wee & Albert M. van Hemert. (2021) The clinical and cost-effectiveness of a self-management intervention for patients with persistent depressive disorder and their partners/caregivers: study protocol of a multicenter pragmatic randomized controlled trial. Trials 22:1.
Crossref
Crossref
Bernard J. Borserio, Christopher F. Sharpley, Vicki Bitsika, Kimaya Sarmukadam, Phillip J. Fourie & Linda L. Agnew. (2021) Default mode network activity in depression subtypes. Reviews in the Neurosciences 32:6, pages 597-613.
Crossref
Crossref
Daryl Wayne Niedermoser, Nadeem Kalak, Martin Meyer, Nina Schweinfurth, Marc Walter & Undine E. Lang. (2021) How a Depressive Medical Doctor Profited in the Long-Term from a New and Short Psychological Group-Treatment against Major Depressive Disorder. International Journal of Environmental Research and Public Health 18:4, pages 1925.
Crossref
Crossref
Allan H. Young, Mario F. Juruena, Renske De Zwaef & Koen Demyttenaere. (2020) Vagus nerve stimulation as adjunctive therapy in patients with difficult-to-treat depression (RESTORE-LIFE): study protocol design and rationale of a real-world post-market study. BMC Psychiatry 20:1.
Crossref
Crossref
Érico Nobre dos Santos, Mariane Lopez Molina, Thaise Mondin, Taiane de Azevedo Cardoso, Ricardo Silva, Luciano Souza & Karen Jansen. (2020) Long-term effectiveness of two models of brief psychotherapy for depression: A three-year follow-up randomized clinical trial. Psychiatry Research 286, pages 112804.
Crossref
Crossref
Daryl Wayne Niedermoser, Nadeem Kalak, Anna Kiyhankhadiv, Serge Brand, Corinna Walter, Nina Schweinfurth & Undine E. Lang. (2020) Workplace-Related Interpersonal Group Psychotherapy to Improve Life at Work in Individuals With Major Depressive Disorders: A Randomized Interventional Pilot Study. Frontiers in Psychiatry 11.
Crossref
Crossref
Candice Fischer, Marianne Cottin, Alex Behn, Paula Errázuriz & Ruben Díaz. (2019)
What makes a difficult patient so
difficult
? Examining the therapist's experience beyond patient characteristics
. Journal of Clinical Psychology 75:5, pages 898-911.
Crossref
Crossref
Djamila Bennabi & Emmanuel Haffen. (2018) Transcranial Direct Current Stimulation (tDCS): A Promising Treatment for Major Depressive Disorder?. Brain Sciences 8:5, pages 81.
Crossref
Crossref